Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma

Laryngoscope

Volumn 109, Issue 5, 1999, Pages 810-814

  Wakisaka, Naohiro ^a   Wen, Qing Hua ^a   Yoshizaki, Tomokazu ^a   Nishimura, Toshiro ^a   Furukawa, Mitsuru ^a   Kawahara, Ei ^a   Nakanishi, Isao ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Lymph node metastasis; Nasopharyngeal carcinoma; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; LYMPHOKINES; NASOPHARYNGEAL NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032914466     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199905000-00024     Document Type: Article

References (28)

1. Cvitkovic E, Bachouchi M, Armand JP. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications. Hematol Oncol Clin North Am 1991;5:821-838.
2. Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci USA 1966;56: 1699-1704.
3. Fahraeus R, Hu LF, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988;42:329-338.
4. Chang Y, Tyan YS, Liu ST, et al. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma by enzymatic DNA amplification. J Clin Microbiol 1990;28: 2398-2402.
5. Howe JG, Steitz JA. Localization of Epstein-Barr virus-encoded RNAs by in situ hybridization. Proc Natl Acad Sci U S A 1986;83:9006-9010.
6. Hsu MM, Tu Sm. Nasopharyngeal carcinoma in Taiwan. Clinical manifestation and results of therapy. Cancer 1983; 52:362-368.
7. Applebaum EL, Mantravadi P, Haas R. Lymphoepithelioma of the nasopharynx. Laryngoscope 1982;92:510-514.
8. Folkman J. Tumor angiogenesis: therapeutic implications N Engl J Med 1971;285:1182-1186.
9. Srivastava A, Laidler P, Hughes LE, et al. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986;22:1205-1209.
10. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastases-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
11. Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
12. Ferrera N, Henzel WJ. Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161: 851-858.
13. Klagsbrun M, Stoker S. VEGF/VPF: the angiogenesis factor found? Curr Biol 1993;3:699-702.
14. Yoshiji H, Gomez DE, Shibuya M, et al. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996;56: 2013-2016.
15. Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;155:3964-3968.
16. Shanmugaratnam K. Histopathological Typing of Upper Respiratory Tract and Ear. 2nd ed. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest: Springer-Verlag; 1991:32-34.
17. UICC. Pharynx. TNM Classification of Malignant Tumors. 4th ed. Berlin, Heidelberg, New York: Springer-Verlag; 1987:19-22.
18. Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
19. Smith SS, Basu PK. Mast cells in corneal immune reaction. Can J Ophthalmol 1970;5:175-183.
20. Roychowdhury DF, Tseng A, Fu KK, et al. Prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer 1996;77:1419-1426.
21. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
22. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
23. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993;48:1120-1128.
24. Quinn TP, Peters KG, De Vries C, et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 1993;90:7533-7537.
25. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 1993;90:8915-8919.
26. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-844.
27. Ferrara N, Winer J, Burton T, et al. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 1993;91:160-170.
28. Borgstrom P, Hillan KJ, Sriramarao P, et al. Complete inhibition of angiogenesis and growth of microtumors by antivascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 1996;56:4032-4039.